Q3 2025 Holdings
Filed 2025-11-14 | 440 holdings | $349.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BlackRock Income TR Inc(BKT-R) | RIGHT 10/20/2025 | 09247F118 | $3.5K | 58,703 | 0.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $18.5K | 2,585 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $48.2K | 11,511 | 0.0% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $58.9K | 8,163 | 0.0% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $60.0K | 15,914 | 0.0% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $75.4K | 12,714 | 0.0% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $79.6K | 5,071 | 0.0% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $84.1K | 14,495 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $84.3K | 40,930 | 0.0% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $86.3K | 52,924 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $87.9K | 9,514 | 0.0% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $88.9K | 4,816 | 0.0% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $95.9K | 1,419 | 0.0% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $96.7K | 5,578 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $99.5K | 7,869 | 0.0% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $100.8K | 81,276 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $100.9K | 2,125 | 0.0% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $101.3K | 13,094 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $104.6K | 3,982 | 0.0% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $105.7K | 20,374 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $105.9K | 8,693 | 0.0% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $107.4K | 22,009 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $107.6K | 11,155 | 0.0% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $107.7K | 6,425 | 0.0% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $108.0K | 2,718 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $108.8K | 4,452 | 0.0% |
| Curevac N V | COM | N2451R105 | $109.5K | 20,319 | 0.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $109.6K | 7,299 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $110.7K | 7,624 | 0.0% |
| Cartesian Therapeutics Inc(RNAC) | COM NEW | 816212302 | $113.6K | 11,112 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $115.1K | 7,138 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $115.7K | 15,804 | 0.0% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $116.6K | 5,644 | 0.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $118.5K | 5,787 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $118.9K | 3,302 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $119.7K | 7,380 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $120.8K | 37,064 | 0.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $124.5K | 21,798 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $126.3K | 1,461 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $126.8K | 8,869 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $127.2K | 3,415 | 0.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $128.1K | 41,987 | 0.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $128.1K | 15,031 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $129.3K | 2,768 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $132.0K | 8,342 | 0.0% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $133.9K | 2,527 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $134.2K | 2,020 | 0.0% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $135.5K | 1,831 | 0.0% |
| Immunome Inc(IMNM) | COM | 45257U108 | $136.1K | 11,623 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $136.2K | 2,406 | 0.0% |